H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Census population 2,304,580. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Houston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Houston storefront.
Skin Substitute Therapy Products in Houston, TX for clinics & physicians. Skin substitute therapy for comp… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of skin substitute therapy in Houston: (1) CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. (2) Texas Part B wound biologics are reviewed by Novitas Solutions under JH, shared with AR, CO, LA, MS, NM, OK. We help with the second file. We do not pretend to be a Houston storefront.
National Skin Substitute Therapy Products notes (how the product actually works)Texas shares JH with AR, CO, LA, MS, NM, OK. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Adult arthritis here is 19.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Houston.
CDC PLACES (2023, crude prevalence) estimates 13.9% of adults — 1.9 points above the U.S. 12% figure. Obesity is 38%; arthritis is 19.3%. That is place-level BRFSS modeling, not a clinic census and not a Houston trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Texas compliance risk.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Houston, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Houston is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Houston — 1.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Houston. Useful for joint-program math; still needs a diagnosis and privileging.
No Houston storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.